NCT03327571View on ClinicalTrials.gov

B-CD30 + Hodgkin Lymphoma International Multi-center Retrospective Study of Treatment Practices and Outcomes

CompletedOBSERVATIONAL
Enrollment

1,770

Participants

Timeline

Start Date

November 21, 2017

Primary Completion Date

October 31, 2019

Study Completion Date

October 31, 2019

Conditions
Classical Hodgkin LymphomaRelapsed or Refractory Classical Hodgkin Lymphoma
Trial Locations (1)

49241

Pusan National University Hospital, Busan

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY